Details of the Drug

General Information of Drug (ID: DM8OOGA)

Drug Name

ANB-019

Indication

Disease Entry	ICD 11	Status	REF
Pustular palmoplantar psoriasis	EA90	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03619902) A Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Generalized Pustular Psoriasis (GPP). U.S. National Institutes of Health.